US$ 22.65
glp-1 gip dual agonist GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Upcoming wave of hormone-based therapies
Description
24 , 473485 (2022) M

95% CI, 0.23 to 9.17

[88].Oh KS, Kim JY, Yoon BD, Lee M, Kim H, Kim M, Seo JH, Yuk SH, Sol-gel transition of nanoparticles/polymer mixtures for sustained delivery of exenatide to treat type 2 diabetes mellitus, European Journal of Pharmaceutics and Biopharmaceutics, 88 (2014) 664669
Front Endocrinol (Lausanne) [Internet]
